XBiotech Inc. (NASDAQ:XBIT – Get Free Report) shares passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $6.99 and traded as high as $7.65. XBiotech shares last traded at $7.39, with a volume of 62,083 shares changing hands.
XBiotech Trading Up 1.2 %
The stock has a fifty day simple moving average of $7.03 and a two-hundred day simple moving average of $7.02. The company has a market cap of $223.90 million, a PE ratio of -6.26 and a beta of 1.41.
XBiotech (NASDAQ:XBIT – Get Free Report) last announced its quarterly earnings data on Monday, August 12th. The biopharmaceutical company reported ($0.43) earnings per share for the quarter.
Institutional Investors Weigh In On XBiotech
About XBiotech
XBiotech Inc, a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation.
See Also
- Five stocks we like better than XBiotech
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What is an Earnings Surprise?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for XBiotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBiotech and related companies with MarketBeat.com's FREE daily email newsletter.